Constellation Pharmaceuticals, Inc.
P300/CBP HAT INHIBITORS AND METHODS FOR THEIR USE
Last updated:
Abstract:
Provided are compounds of Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are useful for treating a variety of conditions associated with histone acetyltransferase (HAT). ##STR00001##
Status:
Application
Type:
Utility
Filling date:
26 Feb 2020
Issue date:
5 May 2022